- Complexes of Guanosine Monophosphate (GMP) with Nickel (II): a NMR relaxation study2000 | Faculty of Mathematics and Physics, Central Library of Charles University
- Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes2018 | Faculty of Science
- Nitric oxide and cyclic guanosine monophosphate: effects on potassium channels and vascular tone1996 | Second Faculty of Medicine
- Study of Mononucleotide G-quadruplexes at low pH by Raman Optical Activity2023 | Faculty of Mathematics and Physics
- Acute hemodynamic effects of Riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1)2014 | First Faculty of Medicine
- Role of NO/cGMP Signaling Pathway in Cardiac Ischemic Tolerance of Chronically Hypoxic Rats2015 | Faculty of Science
- Effect of ribose versus 2 '-deoxyribose residue in guanosine 5 '-monophosphates on formation of G-quartets stabilized by potassium and sodium cations2016 | Faculty of Mathematics and Physics
- Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity2019 | Faculty of Science
- Riociguat, an oral soluble guanylate cyclase stimulator, in the treatment of pulmonary hypertension2016 | First Faculty of Medicine
- Immune sensing of mouse polyomavirus DNA by p204 and cGAS DNA sensors2021 | Faculty of Science
- Review of physiology of insulin/secretion from pancreatic beta-cells2001 | Third Faculty of Medicine
- Development of computational models to decipher Raman optical activity spectra of G-quadruplexes2023 | Faculty of Mathematics and Physics
- The impact of phosphodiesterase-5 inhibition or angiotensin-converting enzyme inhibition on right and left ventricular remodeling in heart failure due to chronic volume overload2024 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Physical Education and Sport
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | First Faculty of Medicine